FDA Flags Potential Guillain-Barre Risk With RSV Vaccine Candidates
Ahead of a 2-day meeting with FDA’s vaccine advisors, reviewers at the agency highlighted a rare but potential risk for Guillain-Barré syndrome with two vaccine candidates for respiratory syncytial virus (RSV). On Tuesday and Wednesday, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) will recommend whether the risk-benefit profile with Pfizer and GSK’s vaccine […]
Mass Shooters’ Common Traits; FDA to Let Gay Men Give Blood; Restaurant Health Fee?
Note that some links may require subscriptions. FDA advisors recommended completely phasing out the original monovalent COVID-19 vaccines in favor of the updated bivalent shots, and also weighed in on the agency’s plan for annual COVID-19 boosters. Nearly all mass attackers were male and experienced at least one significant stressor in the past 5 years, […]
Plan for More Oversight of Pathogen-Related Research Passes Hurdle
On Friday, federal advisors endorsed new recommendations for improving the biosecurity oversight of scientific research involving potential pandemic-causing pathogens. The board of directors of the National Science Advisory Board for Biosecurity (NSABB) voted to approve a proposed framework requiring federal departments to review any research that could potentially enhance the transmissibility or virulence of a […]